{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T17:03:45Z","timestamp":1793984625791,"version":"4.8.0"},"reference-count":146,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The interplay between myeloid cells and T-lymphocytes is critical to the regulation of host defense and inflammation resolution. Dysregulation of this interaction can contribute to the development of chronic inflammatory diseases. Important among these diseases is atherosclerosis, which refers to focal lesions in the arterial intima driven by elevated apolipoprotein B-containing lipoproteins, notably low-density lipoprotein (LDL), and characterized by the formation of a plaque composed of inflammatory immune cells, a collection of dead cells and lipids called the necrotic core, and a fibrous cap. As the disease progresses, the necrotic core expands, and the fibrous cap becomes thin, which increases the risk of plaque rupture or erosion. Plaque rupture leads to a rapid thrombotic response that can give rise to heart attack, stroke, or sudden death. With marked lowering of circulating LDL, however, plaques become more stable and cardiac risk is lowered\u2014a process known as atherosclerosis regression. A critical aspect of both atherosclerosis progression and regression is the crosstalk between innate (myeloid cells) and adaptive (T-lymphocytes) immune cells. Myeloid cells are specialized at clearing apoptotic cells by a process called efferocytosis, which is necessary for inflammation resolution. In advanced disease, efferocytosis is impaired, leading to secondary necrosis of apoptotic cells, inflammation, and, most importantly, defective tissue resolution. In regression, efferocytosis is reawakened aiding in inflammation resolution and plaque stabilization. Here, we will explore how efferocytosing myeloid cells could affect T-cell function and vice versa through antigen presentation, secreted factors, and cell-cell contacts and how this cellular crosstalk may contribute to the progression or regression of atherosclerosis.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1403150","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T07:39:18Z","timestamp":1717054758000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Crosstalk between efferocytic myeloid cells and T-cells and its relevance to atherosclerosis"],"prefix":"10.3389","volume":"15","author":[{"given":"David","family":"Ngai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh R.","family":"Sukka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira","family":"Tabas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,5,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.0000029784.15893.10","article-title":"Innate and adaptive immunity in the pathogenesis of atherosclerosis","volume":"91","author":"Hansson","year":"2002","journal-title":"Circ Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","article-title":"Atherosclerosis","volume":"5","author":"Libby","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"B3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1161\/ATVBAHA.119.312802","article-title":"Macrophages in atherosclerosis regression","volume":"40","author":"Barrett","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.025684","article-title":"The role of efferocytosis in atherosclerosis","volume":"135","author":"Kojima","year":"2017","journal-title":"Circulation"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2017.00086","article-title":"Mechanisms and consequences of defective efferocytosis in atherosclerosis","volume":"4","author":"Yurdagul","year":"2017","journal-title":"Front Cardiovasc Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.119.315939","article-title":"Intracellular and intercellular aspects of macrophage immunometabolism in atherosclerosis","volume":"126","author":"Tabas","year":"2020","journal-title":"Circ Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.045851","article-title":"The expected 30-year benefits of early versus delayed primary prevention of cardiovascular disease by lipid lowering","volume":"142","author":"Pencina","year":"2020","journal-title":"Circulation"},{"key":"B8","doi-asserted-by":"publisher","first-page":"7999","DOI":"10.1038\/s41598-021-87528-w","article-title":"The effects of lipid-lowering therapy on coronary plaque regression: a systematic review and meta-analysis","volume":"11","author":"Li","year":"2021","journal-title":"Sci Rep"},{"key":"B9","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-020-0352-5","article-title":"T cell subsets and functions in atherosclerosis","volume":"17","author":"Saigusa","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.1038\/s41467-021-23909-z","article-title":"Cell-specific and divergent roles of the CD40L-CD40 axis in atherosclerotic vascular disease","volume":"12","author":"Lacy","year":"2021","journal-title":"Nat Commun"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.034076","article-title":"Low-density lipoprotein-reactive T cells regulate plasma cholesterol levels and development of atherosclerosis in humanized hypercholesterolemic mice","volume":"138","author":"Gister\u00e5","year":"2018","journal-title":"Circulation"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s44161-022-00049-1","article-title":"The why and how of adaptive immune responses in ischemic cardiovascular disease","volume":"1","author":"Mallat","year":"2022","journal-title":"Nat Cardiovasc Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/ni1004-971","article-title":"The interface between innate and adaptive immunity","volume":"5","author":"Hoebe","year":"2004","journal-title":"Nat Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.573347","article-title":"Crosstalk between innate and T cell adaptive immunity with(in) the muscle","volume":"11","author":"Bonomo","year":"2020","journal-title":"Front Physiol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101759","article-title":"Innate-adaptive immunity interplay and redox regulation in immune response","volume":"37","author":"Sun","year":"2020","journal-title":"Redox Biol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-0620-x","article-title":"PD-L1 engagement on T cells promotes self-tolerance and suppression of neighboring macrophages and effector T cells in cancer","volume":"21","author":"Diskin","year":"2020","journal-title":"Nat Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.immuni.2018.07.015","article-title":"Regulatory T cells promote macrophage efferocytosis during inflammation resolution","volume":"49","author":"Proto","year":"2018","journal-title":"Immunity"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00055","article-title":"Self-antigen presentation by dendritic cells in autoimmunity","volume":"5","author":"Hopp","year":"2014","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00642","article-title":"Molecular mechanisms of T cells activation by dendritic cells in autoimmune diseases","volume":"9","author":"Tai","year":"2018","journal-title":"Front Pharmacol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1172\/JCI78084","article-title":"Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity","volume":"125","author":"Suurmond","year":"2015","journal-title":"J Clin Invest"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.1031293","article-title":"Defective efferocytosis of vascular cells in heart disease","volume":"9","author":"Singh","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1172\/JCI90520","article-title":"MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis","volume":"127","author":"Cai","year":"2017","journal-title":"J Clin Invest"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2015.161","article-title":"Enhanced efferocytosis by dendritic cells underlies memory T-cell expansion and susceptibility to autoimmune disease in CD300f-deficient mice","volume":"23","author":"Tian","year":"2016","journal-title":"Cell Death Differ"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.118.313591","article-title":"Immunity and inflammation in atherosclerosis","volume":"124","author":"Wolf","year":"2019","journal-title":"Circ Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2013.11.041","article-title":"Plasma autoantibodies against apolipoprotein B-100 peptide 210 in subclinical atherosclerosis","volume":"232","author":"McLeod","year":"2014","journal-title":"Atherosclerosis"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2008.03015.x","article-title":"T-cell receptor binding affinities and kinetics: impact on T-cell activity and specificity","volume":"126","author":"Stone","year":"2009","journal-title":"Immunology"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1413726111","article-title":"A sharp T-cell antigen receptor signaling threshold for T-cell proliferation","volume":"111","author":"Au-Yeung","year":"2014","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-019-00684-7","article-title":"Regulatory T cells: the many faces of foxp3","volume":"39","author":"Georgiev","year":"2019","journal-title":"J Clin Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s00018-022-04328-9","article-title":"Recirculating Foxp3+ regulatory T cells are restimulated in the thymus under Aire control","volume":"79","author":"Charaix","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"B30","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1073\/pnas.0910620107","article-title":"FoxP3+ regulatory T cells essentially contribute to peripheral CD8+ T-cell tolerance induced by steady-state dendritic cells","volume":"107","author":"Schildknecht","year":"2010","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000089083.61317.A1","article-title":"Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice","volume":"108","author":"Mallat","year":"2003","journal-title":"Circulation"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.119.316461","article-title":"Regulatory T cells license macrophage pro-resolving functions during atherosclerosis regression","volume":"127","author":"Sharma","year":"2020","journal-title":"Circ Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-017368","article-title":"Apoptotic cells induce Mer tyrosine kinase-dependent blockade of NF-kappaB activation in dendritic cells","volume":"109","author":"Sen","year":"2007","journal-title":"Blood"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1301693","article-title":"Antigen-specific induced T regulatory cells impair dendritic cell function via an IL-10\/MARCH1-dependent mechanism","volume":"191","author":"Chattopadhyay","year":"2013","journal-title":"J Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1172\/JCI61758","article-title":"Dynamic T cell-APC interactions sustain chronic inflammation in atherosclerosis","volume":"122","author":"Koltsova","year":"2012","journal-title":"J Clin Invest"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2015.26","article-title":"Inflammation-induced foam cell formation in chronic inflammatory disease","volume":"93","author":"Angelovich","year":"2015","journal-title":"Immunol Cell Biol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1080\/08830180902978120","article-title":"Molecular mechanisms of IFN-gamma to up-regulate MHC class I antigen processing and presentation","volume":"28","author":"Zhou","year":"2009","journal-title":"Int Rev Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v98.4.1108","article-title":"Tumor necrosis factor-alpha induces coordinated changes in major histocompatibility class I presentation pathway, resulting in increased stability of class I complexes at the cell surface","volume":"98","author":"Hallermalm","year":"2001","journal-title":"Blood"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.431","article-title":"Rab17 mediates differential antigen sorting following efferocytosis and phagocytosis","volume":"7","author":"Yin","year":"2016","journal-title":"Cell Death Dis"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/nature04596","article-title":"Toll-dependent selection of microbial antigens for presentation by dendritic cells","volume":"440","author":"Blander","year":"2006","journal-title":"Nature"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.04.054","article-title":"TLR signals induce phagosomal MHC-I delivery from the endosomal recycling compartment to allow cross-presentation","volume":"158","author":"Nair-Gupta","year":"2014","journal-title":"Cell"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.631714","article-title":"Cellular responses to the efferocytosis of apoptotic cells","volume":"12","author":"Yin","year":"2021","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1161\/hc5001.100631","article-title":"Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL","volume":"104","author":"Xu","year":"2001","journal-title":"Circulation"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-15-0345","article-title":"Oxidized low-density lipoprotein promotes macrophage lipid accumulation via the toll-like receptor 4-Src pathway","volume":"79","author":"Yang","year":"2015","journal-title":"Circ J"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-021-00726-4","article-title":"Dendritic cell migration in inflammation and immunity","volume":"18","author":"Liu","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.039288","article-title":"Lack of ability to present antigens on major histocompatibility complex class II molecules aggravates atherosclerosis in apoE","volume":"139","author":"Wigren","year":"2019","journal-title":"Circulation"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2008.11.013","article-title":"Dendritic cell antigen presentation drives simultaneous cytokine production by effector and regulatory T cells in inflamed skin","volume":"30","author":"McLachlan","year":"2009","journal-title":"Immunity"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1172\/JCI64617","article-title":"Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs","volume":"123","author":"Subramanian","year":"2013","journal-title":"J Clin Invest"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20042276","article-title":"TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells","volume":"201","author":"Marie","year":"2005","journal-title":"J Exp Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1320319111","article-title":"Thymocyte apoptosis drives the intrathymic generation of regulatory T cells","volume":"111","author":"Konkel","year":"2014","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1791","article-title":"Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis","volume":"10","author":"Murai","year":"2009","journal-title":"Nat Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1304498110","article-title":"Excessive Th1 responses due to the absence of TGF-\u03b2 signaling cause autoimmune diabetes and dysregulated Treg cell homeostasis","volume":"110","author":"Ishigame","year":"2013","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1084\/jem.170.6.2081","article-title":"Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones","volume":"170","author":"Fiorentino","year":"1989","journal-title":"J Exp Med"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.9.5666","article-title":"TGF-beta1 inhibits T-bet induction by IFN-gamma in murine CD4+ T cells through the protein tyrosine phosphatase Src homology region 2 domain-containing phosphatase-1","volume":"175","author":"Park","year":"2005","journal-title":"J Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-09-2798","article-title":"IL-10 and TGF-beta induce alloreactive CD4+CD25- T cells to acquire regulatory cell function","volume":"101","author":"Chen","year":"2003","journal-title":"Blood"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.9.5213","article-title":"Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10","volume":"172","author":"Zheng","year":"2004","journal-title":"J Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1000288","article-title":"TGF-beta enhances effector Th1 cell activation but promotes self-regulation via IL-10","volume":"184","author":"Huss","year":"2010","journal-title":"J Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.2337\/db08-0609","article-title":"Transforming growth factor-beta suppresses the activation of CD8+ T-cells when naive but promotes their survival and function once antigen experienced: a two-faced impact on autoimmunity","volume":"57","author":"Filippi","year":"2008","journal-title":"Diabetes"},{"key":"B59","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.immuni.2018.01.006","article-title":"Interleukin-10 directly inhibits CD8+ T cell function by enhancing N-glycan branching to decrease antigen sensitivity","volume":"48","author":"Smith","year":"2018","journal-title":"Immunity"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0590-4","article-title":"Single-cell immune landscape of human atherosclerotic plaques","volume":"25","author":"Fernandez","year":"2019","journal-title":"Nat Med"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.001347","article-title":"Cytotoxic and proinflammatory CD8+ T lymphocytes promote development of vulnerable atherosclerotic plaques in apoE-deficient mice","volume":"127","author":"Kyaw","year":"2013","journal-title":"Circulation"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.117.304611","article-title":"CD8+ T cells regulate monopoiesis and circulating ly6C-high monocyte levels in atherosclerosis in mice","volume":"117","author":"Cochain","year":"2015","journal-title":"Circ Res"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/nm0804-801","article-title":"Regulatory T cells and mechanisms of immune system control","volume":"10","author":"O\u2019Garra","year":"2004","journal-title":"Nat Med"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-022-00551-7","article-title":"Macrophages use apoptotic cell-derived methionine and DNMT3A during efferocytosis to promote tissue resolution","volume":"4","author":"Ampomah","year":"2022","journal-title":"Nat Metab"},{"key":"B65","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.cmet.2018.12.004","article-title":"Efferocytosis fuels requirements of fatty acid oxidation and the electron transport chain to polarize macrophages for tissue repair","volume":"29","author":"Zhang","year":"2019","journal-title":"Cell Metab"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0735-5","article-title":"Efferocytosis induces a novel SLC program to promote glucose uptake and lactate release","volume":"563","author":"Morioka","year":"2018","journal-title":"Nature"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-023-00736-8","article-title":"PFKFB2-mediated glycolysis promotes lactate-driven continual efferocytosis by macrophages","volume":"5","author":"Schilperoort","year":"2023","journal-title":"Nat Metab"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-023-00921-9","article-title":"Efferocytosis-induced lactate enables the proliferation of pro-resolving macrophages to mediate tissue repair","volume":"5","author":"Ngai","year":"2023","journal-title":"Nat Metab"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-019-0688-7","article-title":"Lactate modulates CD4+ T-cell polarization and induces an immunosuppressive environment, which sustains prostate carcinoma progression via TLR8\/miR21 axis","volume":"38","author":"Comito","year":"2019","journal-title":"Oncogene"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-03045-2","article-title":"Metabolic support of tumour-infiltrating regulatory T cells by lactic acid","volume":"591","author":"Watson","year":"2021","journal-title":"Nature"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111122","article-title":"Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-\u03b2 signaling in regulatory T cells","volume":"40","author":"Gu","year":"2022","journal-title":"Cell Rep"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108500","article-title":"Lactate limits T cell proliferation via the NAD(H) redox state","volume":"33","author":"Quinn","year":"2020","journal-title":"Cell Rep"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.cmet.2019.10.004","article-title":"Lactate buildup at the site of chronic inflammation promotes disease by inducing CD4+ T cell metabolic rewiring","volume":"30","author":"Pucino","year":"2019","journal-title":"Cell Metab"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2013.02.014","article-title":"Association of blood lactate with carotid atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study","volume":"228","author":"Shantha","year":"2013","journal-title":"Atherosclerosis"},{"key":"B75","doi-asserted-by":"publisher","first-page":"2743S","DOI":"10.1093\/jn\/134.10.2743S","article-title":"Enzymes of arginine metabolism","volume":"134","author":"Morris","year":"2004","journal-title":"J Nutr"},{"key":"B76","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.cmet.2020.01.001","article-title":"Macrophage metabolism of apoptotic cell-derived arginine promotes continual efferocytosis and resolution of injury","volume":"31","author":"Yurdagul","year":"2020","journal-title":"Cell Metab"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.110222","article-title":"Polyamine import and accumulation causes immunomodulation in macrophages engulfing apoptotic cells","volume":"38","author":"McCubbrey","year":"2022","journal-title":"Cell Rep"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M804714200","article-title":"Identification and characterization of a diamine exporter in colon epithelial cells","volume":"283","author":"Uemura","year":"2008","journal-title":"J Biol Chem"},{"key":"B79","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jaci.2020.04.037","article-title":"Regulating T-cell differentiation through the polyamine spermidine","volume":"147","author":"Carriche","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"4186","DOI":"10.1016\/j.cell.2021.06.007","article-title":"Polyamine metabolism is a central determinant of helper T cell lineage fidelity","volume":"184","author":"Puleston","year":"2021","journal-title":"Cell"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abc4275","article-title":"De novo synthesis and salvage pathway coordinately regulate polyamine homeostasis and determine T cell proliferation and function","volume":"6","author":"Wu","year":"2020","journal-title":"Sci Adv"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2305245120","article-title":"Tumor cell-derived spermidine is an oncometabolite that suppresses TCR clustering for intratumoral CD8+ T cell activation","volume":"120","author":"Hibino","year":"2023","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.169308","article-title":"Modulating the polyamine\/hypusine axis controls generation of CD8+ tissue-resident memory T cells","volume":"8","author":"Elmarsafawi","year":"2023","journal-title":"JCI Insight"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht329","article-title":"Arginase I enhances atherosclerotic plaque stabilization by inhibiting inflammation and promoting smooth muscle cell proliferation","volume":"35","author":"Wang","year":"2014","journal-title":"Eur Heart J"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800016","article-title":"IL-6 promotes T cell proliferation and expansion under inflammatory conditions in association with low-level ROR\u03b3t expression","volume":"201","author":"Li","year":"2018","journal-title":"J Immunol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2109972118","article-title":"TNF plays a crucial role in inflammation by signaling via T cell TNFR2","volume":"118","author":"Alam","year":"2021","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2019.110797","article-title":"Kynurenine signaling through the aryl hydrocarbon receptor: Implications for aging and healthspan","volume":"130","author":"Kaiser","year":"2020","journal-title":"Exp Gerontol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0107-1","article-title":"Apoptotic cell-induced AhR activity is required for immunological tolerance and suppression of systemic lupus erythematosus in mice and humans","volume":"19","author":"Shinde","year":"2018","journal-title":"Nat Immunol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1038\/s41467-018-04366-7","article-title":"Single cell analysis of kynurenine and System L amino acid transport in T cells","volume":"9","author":"Sinclair","year":"2018","journal-title":"Nat Commun"},{"key":"B90","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.molcel.2022.02.007","article-title":"Kynurenine importation by SLC7A11 propagates anti-ferroptotic signaling","volume":"82","author":"Fiore","year":"2022","journal-title":"Mol Cell"},{"key":"B91","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.ccell.2018.02.005","article-title":"Tumor-repopulating cells induce PD-1 expression in CD8+ T cells by transferring kynurenine and ahR activation","volume":"33","author":"Liu","year":"2018","journal-title":"Cancer Cell"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.9.1363","article-title":"Inhibition of T cell proliferation by macrophage tryptophan catabolism","volume":"189","author":"Munn","year":"1999","journal-title":"J Exp Med"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903670","article-title":"An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells","volume":"185","author":"Mezrich","year":"2010","journal-title":"J Immunol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1915","article-title":"Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells","volume":"11","author":"Gandhi","year":"2010","journal-title":"Nat Immunol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nature06880","article-title":"Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor","volume":"453","author":"Quintana","year":"2008","journal-title":"Nature"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00950","article-title":"Activation of the regulatory T-cell\/indoleamine 2,3-dioxygenase axis reduces vascular inflammation and atherosclerosis in hyperlipidemic mice","volume":"9","author":"Forteza","year":"2018","journal-title":"Front Immunol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/joim.13142","article-title":"Evidence that a deviation in the kynurenine pathway aggravates atherosclerotic disease in humans","volume":"289","author":"Baumgartner","year":"2021","journal-title":"J Intern Med"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-04-423525","article-title":"Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators","volume":"120","author":"Dalli","year":"2012","journal-title":"Blood"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1524292113","article-title":"MerTK cleavage limits proresolving mediator biosynthesis and exacerbates tissue inflammation","volume":"113","author":"Cai","year":"2016","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2022.01.002","article-title":"Macrophage COX2 mediates efferocytosis, resolution reprogramming, and intestinal epithelial repair","volume":"13","author":"Meriwether","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.02447","article-title":"PGE2 augments inflammasome activation and M1 polarization in macrophages infected with salmonella typhimurium and yersinia enterocolitica","volume":"9","author":"Sheppe","year":"2018","journal-title":"Front Microbiol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2015.05.003","article-title":"Lipoxin A4 attenuates obesity-induced adipose inflammation and associated liver and kidney disease","volume":"22","author":"B\u00f6rgeson","year":"2015","journal-title":"Cell Metab"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.4.1663","article-title":"Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages","volume":"164","author":"Godson","year":"2000","journal-title":"J Immunol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1096\/fj.201902126R","article-title":"Resolvin D1 promotes efferocytosis in aging by limiting senescent cell-induced MerTK cleavage","volume":"34","author":"Rymut","year":"2020","journal-title":"FASEB J"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1100225","article-title":"Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype","volume":"187","author":"Titos","year":"2011","journal-title":"J Immunol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0063296","article-title":"Efferocytosis promotes suppressive effects on dendritic cells through prostaglandin E2 production in the context of autoimmunity","volume":"8","author":"Pujol-Autonell","year":"2013","journal-title":"PloS One"},{"key":"B107","doi-asserted-by":"publisher","first-page":"353ra111","DOI":"10.1126\/scitranslmed.aaf7483","article-title":"Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses","volume":"8","author":"Chiurchi\u00f9","year":"2016","journal-title":"Sci Transl Med"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1500610","article-title":"Female-specific downregulation of tissue polymorphonuclear neutrophils drives impaired regulatory T cell and amplified effector T cell responses in autoimmune dry eye disease","volume":"195","author":"Gao","year":"2015","journal-title":"J Immunol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20082293","article-title":"Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2\/EP4 receptor signaling","volume":"206","author":"Boniface","year":"2009","journal-title":"J Exp Med"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1038\/ncomms2684","article-title":"Prostaglandin E2 promotes Th1 differentiation via synergistic amplification of IL-12 signalling by cAMP and PI3-kinase","volume":"4","author":"Yao","year":"2013","journal-title":"Nat Commun"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13417","article-title":"Prostaglandin E2 directly inhibits the conversion of inducible regulatory T cells through EP2 and EP4 receptors via antagonizing TGF-\u03b2 signaling","volume":"164","author":"Goepp","year":"2021","journal-title":"Immunology"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12859","article-title":"An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques","volume":"7","author":"Fredman","year":"2016","journal-title":"Nat Commun"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.309492","article-title":"Resolving lipid mediators maresin 1 and resolvin D2 prevent atheroprogression in mice","volume":"119","author":"Viola","year":"2016","journal-title":"Circ Res"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115357","article-title":"Role of prostaglandin E2 in macrophage polarization: Insights into atherosclerosis","volume":"207","author":"Wang","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.plefa.2013.04.004","article-title":"The role of prostaglandin E2 in human vascular inflammation","volume":"89","author":"Gomez","year":"2013","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00561","article-title":"PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome","volume":"8","author":"Alsaab","year":"2017","journal-title":"Front Pharmacol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20090847","article-title":"PD-L1 regulates the development, maintenance, and function of induced regulatory T cells","volume":"206","author":"Francisco","year":"2009","journal-title":"J Exp Med"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2021.2024941","article-title":"MerTK-mediated efferocytosis promotes immune tolerance and tumor progression in osteosarcoma through enhancing M2 polarization and PD-L1 expression","volume":"11","author":"Lin","year":"2022","journal-title":"Oncoimmunology"},{"key":"B119","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ccell.2022.01.001","article-title":"Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments","volume":"40","author":"Kumagai","year":"2022","journal-title":"Cancer Cell"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.694145","article-title":"TGF-\u03b21 induces immune escape by enhancing PD-1 and CTLA-4 expression on T lymphocytes in hepatocellular carcinoma","volume":"11","author":"Bao","year":"2021","journal-title":"Front Oncol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2004.02478.x","article-title":"Differential expression of CTLA-4 among T cell subsets","volume":"136","author":"Jago","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.14348\/molcells.2022.2056","article-title":"Current understanding of cytotoxic T lymphocyte antigen-4 (CTLA-4) signaling in T-cell biology and disease therapy","volume":"45","author":"Kim","year":"2022","journal-title":"Mol Cells"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.162.10.5813","article-title":"CTLA-4-Mediated inhibition of early events of T cell proliferation","volume":"162","author":"Brunner","year":"1999","journal-title":"J Immunol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200838603","article-title":"CTLA-4 is required by CD4+CD25+ Treg to control CD4+ T-cell lymphopenia-induced proliferation","volume":"39","author":"Sojka","year":"2009","journal-title":"Eur J Immunol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2023739118","article-title":"Treg-expressed CTLA-4 depletes CD80\/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells","volume":"118","author":"Tekguc","year":"2021","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1126\/science.1160062","article-title":"CTLA-4 control over Foxp3+ regulatory T cell function","volume":"322","author":"Wing","year":"2008","journal-title":"Science"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2004.06.017","article-title":"B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse","volume":"21","author":"Pentcheva-Hoang","year":"2004","journal-title":"Immunity"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-022-01289-w","article-title":"Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation","volume":"23","author":"Kennedy","year":"2022","journal-title":"Nat Immunol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1126\/science.1202947","article-title":"Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4","volume":"332","author":"Qureshi","year":"2011","journal-title":"Science"},{"key":"B130","doi-asserted-by":"publisher","first-page":"R176","DOI":"10.1186\/ar2865","article-title":"CTLA4-Ig interacts with cultured synovial macrophages from rheumatoid arthritis patients and downregulates cytokine production","volume":"11","author":"Cutolo","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"B131","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s13075-021-02691-9","article-title":"CTLA4-Ig treatment induces M1-M2 shift in cultured monocyte-derived macrophages from healthy subjects and rheumatoid arthritis patients","volume":"23","author":"Cutolo","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1038\/ni1003","article-title":"Modulation of tryptophan catabolism by regulatory T cells","volume":"4","author":"Fallarino","year":"2003","journal-title":"Nat Immunol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1320924111","article-title":"Marginal zone CD169+ macrophages coordinate apoptotic cell-driven cellular recruitment and tolerance","volume":"111","author":"Ravishankar","year":"2014","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2024.01.019","article-title":"Lactate modulates RNA splicing to promote CTLA-4 expression in tumor-infiltrating regulatory T cells","volume":"57","author":"Ding","year":"2024","journal-title":"Immunity"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1172\/JCI31344","article-title":"Proatherogenic immune responses are regulated by the PD-1\/PD-L pathway in mice","volume":"117","author":"Gotsman","year":"2007","journal-title":"J Clin Invest"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.111.224709","article-title":"Impairment of the programmed cell death-1 pathway increases atherosclerotic lesion development and inflammation","volume":"31","author":"Bu","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2022.101527","article-title":"PD-1\/PD-L1 blockade accelerates the progression of atherosclerosis in cancer patients","volume":"48","author":"Dong","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.jaccao.2022.11.011","article-title":"Atherosclerosis with immune checkpoint inhibitor therapy: evidence, diagnosis, and management","volume":"4","author":"Suero-Abreu","year":"2022","journal-title":"JACC CardioOncol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.3390\/cells9091987","article-title":"Antibody-mediated inhibition of CTLA4 aggravates atherosclerotic plaque inflammation and progression in hyperlipidemic mice","volume":"9","author":"Poels","year":"2020","journal-title":"Cells"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.115.306848","article-title":"Overexpression of cytotoxic T-lymphocyte-associated antigen-4 prevents atherosclerosis in mice","volume":"36","author":"Matsumoto","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.049981","article-title":"Association between immune checkpoint inhibitors with cardiovascular events and atherosclerotic plaque","volume":"142","author":"Drobni","year":"2020","journal-title":"Circulation"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-024-00731-2","article-title":"Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis","author":"Astuti","year":"2024","journal-title":"Nat Cancer"},{"key":"B143","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12964-020-00542-9","article-title":"Regulation of efferocytosis as a novel cancer therapy","volume":"18","author":"Zhou","year":"2020","journal-title":"Cell Commun Signal"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.1113739","article-title":"Lactate in the tumor microenvironment: A rising star for targeted tumor therapy","volume":"10","author":"Li","year":"2023","journal-title":"Front Nutr"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003013","article-title":"Immunosuppressive metabolites in tumoral immune evasion: redundancies, clinical efforts, and pathways forward","volume":"9","author":"Jennings","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B146","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","article-title":"Inference and analysis of cell-cell communication using CellChat","volume":"12","author":"Jin","year":"2021","journal-title":"Nat Commun"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1403150\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T07:39:41Z","timestamp":1717054781000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1403150\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,30]]},"references-count":146,"alternative-id":["10.3389\/fimmu.2024.1403150"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1403150","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,30]]},"article-number":"1403150"}}